Literature DB >> 10378698

Reassessing the role of C-MYB in tumorigenesis.

K Weston1.   

Abstract

Hematopoietic tumors in both humans and mice frequently up-regulate expression of the c-myb gene, but it is unclear whether this is a cause or a consequence of the leukemic state. Recent results placing super-activation of the c-Myb protein at the bottom of a kinase-activated signal transduction pathway indicate that it may be a downstream effector of transformation induced by other oncogenes. The relationship between c-Myb and the serine-threonine kinase pim-1, its immediate activator, is discussed, together with the possibility that c-Myb, like pim-1, may be able to synergize with c-Myc to induce tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10378698     DOI: 10.1038/sj.onc.1202728

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.

Authors:  C M Eischen; D Woo; M F Roussel; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Chromosome 6 abnormalities correlated with thymoma progression.

Authors:  Hidefumi Sasaki; Yoshitaka Fujii; Nobuyuki Ide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

4.  Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.

Authors:  Feng Fang; Jiamao Zheng; Traci L Galbaugh; Alyson A Fiorillo; Elizabeth E Hjort; Xianke Zeng; Charles V Clevenger
Journal:  J Mol Endocrinol       Date:  2010-03-17       Impact factor: 5.098

5.  c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.

Authors:  Jay L Hess; Claudia B Bittner; Deniz T Zeisig; Christian Bach; Uta Fuchs; Arndt Borkhardt; Jon Frampton; Robert K Slany
Journal:  Blood       Date:  2006-02-28       Impact factor: 22.113

6.  Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.

Authors:  Guo-shun Shu; Fang Lv; Zhu-lin Yang; Xiong-ying Miao
Journal:  Int J Clin Oncol       Date:  2012-06-21       Impact factor: 3.402

7.  A novel yeast system for in vivo selection of recognition sequences: defining an optimal c-Myb-responsive element.

Authors:  T Berge; S L Bergholtz; K B Andersson; O S Gabrielsen
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

8.  Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer.

Authors:  Feng Fang; Ayanna J Flegler; Pan Du; Simon Lin; Charles V Clevenger
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

9.  c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Authors:  Shenghao Jin; Huiwu Zhao; Yan Yi; Yuji Nakata; Anna Kalota; Alan M Gewirtz
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

10.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

Authors:  Feng Fang; Michael A Rycyzyn; Charles V Clevenger
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.